Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 10, 2018 - Issue
Submit an article Journal homepage
348
Views
15
CrossRef citations to date
0
Altmetric
Review

A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions

Naghmeh Foroutan1 Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, ON, Canada, [email protected];2 Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe’s, St Joseph’s Healthcare Hamilton, Hamilton, ON, Canada, [email protected]Correspondence[email protected]
,
Jean-Eric Tarride1 Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, ON, Canada, [email protected];2 Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe’s, St Joseph’s Healthcare Hamilton, Hamilton, ON, Canada, [email protected];3 Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, ON, Canada
,
Feng Xie1 Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, ON, Canada, [email protected];3 Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, ON, Canada;4 Program for Health Economics and Outcome Measures (PHENOM), Hamilton, ON, Canada
&
Mitchell Levine1 Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, ON, Canada, [email protected];2 Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe’s, St Joseph’s Healthcare Hamilton, Hamilton, ON, Canada, [email protected];3 Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, ON, Canada
Pages 821-854 | Published online: 26 Nov 2018

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Ghader Mohammadnezhad, Melika Sattarpour & Najmeh Moradi. (2022) Budget impact analysis of breast cancer medications: a systematic review. Journal of Pharmaceutical Policy and Practice 15:1.
Read now
Daniel Resende Faleiros, Everton Nunes da Silva, Andreia C Santos, Brian B. Godman, Ramon Goncalves Pereira & Augusto A Guerra Junior. (2022) Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions. Expert Review of Pharmacoeconomics & Outcomes Research 22:6, pages 927-939.
Read now
Daniel Resende Faleiros, Juliana Alvares-Teodoro, Everton Nunes da Silva, Brian B. Godman, Ramon Gonçalves Pereira, Eli Iola Gurgel Andrade, Francisco A. de Assis Acurcio & Augusto A. Guerra Júnior. (2022) Budget impact analysis of medicines: estimated values versus real-world evidence and the implications. Expert Review of Pharmacoeconomics & Outcomes Research 22:2, pages 271-281.
Read now

Articles from other publishers (12)

Ramon Schaefer, Diego Hernández, Till Bärnighausen, Peter Kolominsky-Rabas & Michael Schlander. (2023) Health Technology Assessment–Informed Decision Making by the Federal Joint Committee/Institute for Quality and Efficiency in Health Care in Germany and the National Institute for Health and Care Excellence in England: The Role of Budget Impact. Value in Health 26:7, pages 1032-1044.
Crossref
Carlos Rojas-Roque & Alfredo Palacios. (2023) A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America. Applied Health Economics and Health Policy 21:3, pages 419-440.
Crossref
Patrícia Véras Marrone, Fabio Rampazzo Mathias, Wanderley Marques Bernardo, Marina Feliciano Orlandini, Maria Carolina Andrade Serafim, Maria Lídia Rebello Pinho Dias Scoton, Juliano Marçal Lopes, Sérgio Luiz Pereira & Eduardo Mario Dias. (2023) Decision Criteria for Partial Nationalization of Pharmaceutical Supply Chain: A Scoping Review. Economies 11:1, pages 25.
Crossref
Rod Ling, Michelle Giles & Andrew Searles. (2022) Budget impact analysis of a multifaceted nurse-led intervention to reduce indwelling urinary catheter use in New South Wales Hospitals. BMC Health Services Research 22:1.
Crossref
Yiling Jiang, Eric M. Sarpong, Pamela Sears & Engels N. Obi. (2021) Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States. Infectious Diseases and Therapy 11:1, pages 111-126.
Crossref
Mark Hofmeister & Fiona Clement. (2022) Increasing the impact of budget impact analysis: incorporating uncertainty for decision-makers in small markets. International Journal of Technology Assessment in Health Care 38:1.
Crossref
Yashika Chugh, Maria De Francesco & Shankar Prinja. (2021) Systematic Literature Review of Guidelines on Budget Impact Analysis for Health Technology Assessment. Applied Health Economics and Health Policy 19:6, pages 825-838.
Crossref
Michael Kossmeier, Madeleine Themanns, Lena Hatapoglu, Bernhard Kogler, Simon Keuerleber, Jutta Lichtenecker, Robert Sauermann, Anna Bucsics, Michael Freissmuth & Eva Zebedin-Brandl. (2021) Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria. Frontiers in Pharmacology 12.
Crossref
Khadidja Abdallah, Isabelle Huys, Kathleen Claes & Steven Simoens. (2021) Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic Review. Frontiers in Pharmacology 12.
Crossref
Jean-Michel Josselin, Laurie Rachet Jacquet, Véronique Raimond & Lise Rochaix. 2020. Encyclopedia of Law and Economics. Encyclopedia of Law and Economics 1 9 .
Naghmeh Foroutan, Jean-Eric Tarride, Feng Xie, Bismah Jameel, Fergal Mills & Mitchell Levine. (2020) Stakeholders’ feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines. Journal of Population Therapeutics & Clinical Pharmacology 27:1, pages e1-e24.
Crossref
Naghmeh Foroutan, Jean-Eric Tarride, Feng Xie, Fergal Mills & Mitchell Levine. (2019) A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers. PharmacoEconomics - Open 3:4, pages 437-451.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.